Asia - South

The Drug Controller General of India has asked the state drug regulators and the National Pharma Pricing Authority to enforce the maximum retail price of the experimental Covid-19 drug Remdesivir.

Drugmaker Mylan NV is launching its generic version of Gilead Sciences Inc's COVID-19 treatment remdesivir in India this month at 4,800 rupees ($64.31) per 100 mg vial.

China's military announces it will begin using a new coronavirus vaccine on its troops. Is this a breakthrough, or is the PLA feeling political pressure, and moving too fast?

Indian's NPPA has allowed a one-time price increase of 50% on the price of Heparin injection — used in treatment of Covid-19 patients.

A vaccine developed by a Chinese company in collaboration with the Canadian government will skip a final phase of testing and will be used on Chinese soldiers.

Unilever and Johnson & Johnson have agreed to either discontinue or rebrand its skin-whitening products sold across Asia following a backlash over how they're marketed.

The privately held company said it would supply 20,000 vials of the drug.

The oral antiviral drug, favipiravir, which is being used to treat patients with mild to moderate symptoms and infection will now also be available in the Indian market by the name FabiFlu.

With border tensions rising, India is trying to reduce its significant dependency on China for pharmaceutical raw materials.

Various regulations have been issued to control the price of medicines in favor of the Philippine consumers, especially while facing the Covid-19 pandemic.

Combating sickle cell disease in India.

Thai epidemiologists say their health care system — one of the finest in the world — had a major role to play. So did a strict lockdown.

If the U.S. wants lower costs, better outcomes, faster innovation and universal access, it should look to the country that has the closest thing to a functioning health-care market: Singapore.

The rise in cost of imports from China is only one component of the increased cost structure for many of the pharma units.

The government has promised that every Singaporean who needs a COVID-19 vaccine will get one affordably when it's available.